What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Statistics
Her primary areas of study are Internal medicine, Women's Health Initiative, Breast cancer, Gynecology and Hazard ratio.
Garnet L. Anderson has researched Internal medicine in several fields, including Elemental calcium and Surgery.
Her work deals with themes such as Clinical trial, Cohort study, Randomized controlled trial, Physical therapy and Hormone replacement therapy, which intersect with Women's Health Initiative.
The Breast cancer study combines topics in areas such as Skin cancer and Obstetrics.
Her work carried out in the field of Gynecology brings together such families of science as Relative risk, Medroxyprogesterone acetate, Placebo, Menopause and Hormone therapy.
In Hazard ratio, she works on issues like Incidence, which are connected to Proportional hazards model and Epidemiology.
Her most cited work include:
- Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial (12759 citations)
- Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial (3739 citations)
- Design of the Women's Health Initiative clinical trial and observational study (1868 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Internal medicine, Women's Health Initiative, Breast cancer, Gynecology and Randomized controlled trial.
Her research ties Oncology and Internal medicine together.
Garnet L. Anderson works mostly in the field of Women's Health Initiative, limiting it down to concerns involving Clinical trial and, occasionally, Cohort study and Family medicine.
Her study in Breast cancer is interdisciplinary in nature, drawing from both Incidence, Placebo, Menopause, Obstetrics and Risk factor.
Her Gynecology research incorporates elements of Hysterectomy, Progestin, Medroxyprogesterone acetate, Relative risk and Breast disease.
Her research investigates the link between Randomized controlled trial and topics such as Physical therapy that cross with problems in Intervention.
She most often published in these fields:
- Internal medicine (59.73%)
- Women's Health Initiative (38.57%)
- Breast cancer (37.20%)
What were the highlights of her more recent work (between 2015-2021)?
- Women's Health Initiative (38.57%)
- Internal medicine (59.73%)
- Breast cancer (37.20%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Women's Health Initiative, Internal medicine, Breast cancer, Randomized controlled trial and Hazard ratio.
The concepts of her Women's Health Initiative study are interwoven with issues in Cancer, Endometrial cancer, Incidence, Gynecology and Cohort.
She interconnects Endocrinology and Oncology in the investigation of issues within Internal medicine.
Her studies in Breast cancer integrate themes in fields like Weight loss, Medroxyprogesterone acetate, White, Placebo and Obstetrics.
Garnet L. Anderson works mostly in the field of Randomized controlled trial, limiting it down to topics relating to Physical therapy and, in certain cases, Cognitive behavioral therapy for insomnia, as a part of the same area of interest.
Her Hazard ratio research is multidisciplinary, relying on both Prospective cohort study, Proportional hazards model and Risk factor.
Between 2015 and 2021, her most popular works were:
- Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence (122 citations)
- Low-fat dietary pattern and breast cancer mortality in the Women's Health Initiative randomized controlled trial (50 citations)
- Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. (45 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Garnet L. Anderson mainly investigates Internal medicine, Women's Health Initiative, Breast cancer, Randomized controlled trial and Cohort.
Her Internal medicine study combines topics in areas such as Endocrinology and Oncology.
She has included themes like Cancer, Gynecology, Estrogen and Incidence in her Women's Health Initiative study.
Her research in Breast cancer intersects with topics in Body mass index, Menopause and Hazard ratio.
Her biological study spans a wide range of topics, including Observational study, Breast cancer mortality, Adverse effect, Diet therapy and Physical therapy.
Her Cohort research incorporates themes from Biomarker, Physiology, Micronutrient and Nutritional epidemiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
